-
Human immunodeficiency virus (HIV) is the patho-gen of acquired immunodeficiency syndrome (AIDS). Now AIDS is epidemic all over the world. Establish-ment of the non-human primate models for AIDS research has been a major focus of vaccine develop-ment and pathogenesis researches since the discovery of AIDS (7, 8). Although chimpanzees are susceptible to HIV-1 infection, it is generally acknowledged that they are less suitable for AIDS research because they rarely develop disease after HIV infection (4). Natural simian immunodeficiency virus (SIV) infection is widespread in feral populations of African monkeys, but this infection does not result in immunodeficiency (14). SIV and Simian/human immunodeficiency virus (SHIV) infect macaques and result in an immunodeficiency syndrome that is remarkably similar to that in HIV infected humans. Thus, SIV/macaques and SHIV/ macaques models have been usually used to study the pathogenesis of HIV/AIDS as well as evaluation of drugs and vaccines (6, 15).
SIVmac239 and SIVmac251 are commonly used SIV strains. Both strains are originally isolated from breeding rhesus monkeys, and they are pathogenic to rhesus macaques (3, 11). SIVmac239 is an important immunodeficiency virus strain, because SIVmac239 is used to construct SHIVs as backbone. And many attenuated SIV strains are also constructed by deleting the pathogenic gene of SIVmac239 (12, 13). SIV-mac251 is usually used in China (5, 10). To further understand HIV-1 pathogenesis and find better vaccine and drug, two Chinese rhesus macaques were inoculated with SIVmac239 to establish non-human primate AIDS animal model in the present study.
HTML
-
Three Chinese rhesus macaques from Kunming Primate Research Center, Chinese Academy of Sci-ences (CAS), were housed at an Animal Biosafety Level 3 (ABSL-3) laboratory and used in this study. All animals were screened and found to be negative for simian type D retrovirus (SRV) and SIV by antibody ELISA and polymerase chain reaction (PCR) prior to use. Macaques were restrained with ketamine hydrochloride (10 mg/kg of body weight) before virus inoculation and blood collection. Housing, mainte-nance and care of the animals were performed in accordance with the regulations and recommendations of the Animal Care Committee of Kunming Institute of Zoology, CAS.The clones p239SpSp5' and p239-SpE3' kindly donated by Prof. Gao Bin of Institute of Microbiology, CAS, were used for generating the infectious pathogenic SIVmac239. The Virus stocks were propagated in CEMx174 cells and stocked at -80 ℃. The frozen aliquots of the titered virus were quickly thawed before intravenous inoculation.
Both macaques (#99003 and #99083) were ino-culated intravenously with 5000 TCID50 of cell-free SIVmac239, and phosphate-buffered saline (PBS) was injected in macaque #98081 as the negative control. The whole blood was collected from all monkeys in EDTA-K2 tubes at days 0, 7, 14, 21, 35, 64, 78, 92, 99, 106, 113, 121 thereafter. Infected animal were euthanized on day 121 after infection.
-
The number of CD4+ and CD8+ T lymphocytes in peripheral blood was determined using the Tru-CountTM (Becton Dickinson, San Jose, CA, USA) method by flow cytometry. In briefly, blood samples were stained with the fluorochrome-conjugated mono-clonal antibodies to CD3-PE, CD4-PerCP (Becton Dickinson, San Jose, CA, USA) for analysis on a Becton Dickinson FACSCalibur flow cytometery (New Jersey, United States) according to manufac-turer's protocols.
-
Plasma viral load were determined by TaqMan real-time RT-PCR. The RNA copy number was determined by using an external standard curve based on in vitro transcripts representing 1624 to 1985 nt of the SIVmac239 genome with primer A (Table 1) (Genbank Accession Number M33262). The assay had a sensitivity of 180 RNA copies per mL of plasma and the linear dynamic range was from 102 to 108 copies/mL (R2 = 0.99). Viral RNA was purified from 0.3 mL of plasma with TRIzol (MRC, Cincinnati, US) and finally dissolved in 30 μL of RNase free dH2O. Viral RNA was then converted to cDNA using PrimeScriptTM RT reagent Kit according to the manufacture' instruction (TAKARA, Dalian, China). The 149-bp SIVmac239 gag gene fragment primer was primer B, and probe C was used in real-time PCR (Table 1). SIV gag gene amplification was carried out using Premix Ex TaqTM (Perfect Real Time) kit (TAKARA, Dalian, China), and the amplication condition was as follows: one cycle of 10 seconds at 94 ℃ and 40 cycles in two steps each (94 ℃ for 5 s, 60 ℃ for 30 s).
Table 1. PCR Primer pairs and probe
-
Cell-associated infectious viruses were isolated by co-cultivation of rhesus macaque peripheral blood mononuclear cells (PBMC) with 2×105 CEMx174 cells in RPMI 1640 containing 10% FBS in 24-well plates. The cultures were observed for cytopathic effect (CPE) under a light microscope, and virus production was monitored by PCR using primer A (Table 1).
-
Proviral DNA in PBMCs of inoculated monkeys was detected by nested PCR as described previously (2). Briefly, the first PCR round using primer D has the following cycle profile: 95 ℃ for 10 min, followed by 35 cycles of 95 ℃ for 55 sec, 56 ℃ for 30 sec, 72 ℃ for 28 sec, and 72 ℃ for 10 min. For the second round, 0.5 μL products from the first round were amplified using the same profile of the first round, primer E was used (Table 1). PCR products were separated by agarose gel electrophoresis and stained with ethidium bromide.
-
SIV specific antibodies were assayed by ELISA method. Briefly, PEG purified and TNE solution disolved SIV antigen were coated in ELISA plates, and plasma antibody was then detected according to ELISA procedure.